Stock Quote
DaVita Inc. (DVA) (NYSE Arca)
$59.45
12:56pm EST
+0.85%
$58.95
$58.94
270,946
$59.75
$58.94
$59.93
$41.21
0.49
594,275
DVA
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Thiry, Kent | Chairman of the Board, Chief Executive Officer | 11,047,100 |
| Whitney, Richard | Chief Financial Officer | 1,968,080 |
| Kogod, Dennis | Chief Operating Officer | 2,614,080 |
Profile
DaVita Inc. is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2008, the Company operated or provided administrative services to 1,449 outpatient dialysis centers located in 43... Full Description
Company Address
DaVita Inc.
601 Hawaii Street
El Segundo CA 90245
P: +1310.5362400
F: +1310.7928928
601 Hawaii Street
El Segundo CA 90245
P: +1310.5362400
F: +1310.7928928
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | €35.78 | +0.01 |
| DVA | Industry | |
|---|---|---|
| P/E(TTM) | 14.96 | 10.45 |
| P/S(TTM) | 1.00 | 1.18 |
| ROI(TTM) | 7.53 | 4.30 |
| ROE(TTM) | 20.34 | 8.83 |
| Consensus Recommendation | Buy |
|---|---|
| EPS Est. (Current Period) | 1.04 |
| EPS Est. (Current Year) | 4.06 |
| Total Revenue | $1,573.92M |
| Net Income | $126.27M |
| EPS | $1.06 |
